发明名称 MARKER PEPTIDES FOR DETERMINING THE OCCURRENCE OF AN INFLAMMATORY STATE IN A SUBJECT
摘要 An enzyme proteolysis-resistant peptide that binds to antibodies directed against the amino acid region 1-116 of the endocan's polypeptide sequence, which peptide possesses an apparent molecular weight of 14 kDa.
申请公布号 US2015168399(A1) 申请公布日期 2015.06.18
申请号 US201514621427 申请日期 2015.02.13
申请人 Inserm (Institut National De La Sante Et De La Recherche Medicale) ;Institut Pasteur De Lille 发明人 DE FREITAS CAIRES Nathalie;LASSALLE Philippe;HAUW Philippe
分类号 G01N33/566 主分类号 G01N33/566
代理机构 代理人
主权项 1. A method for determining the occurrence of an inflammatory state in a subject, comprising the steps of: a) providing a sample previously collected from the said subject, b) measuring the amount value of: (i) at least one enzyme proteolysis-resistant peptide that binds to antibodies directed against the amino acid region 1-116 of the endocan polypeptide sequence of SEQ ID NO: 1, which peptide possesses an apparent molecular weight of 14 kDa, and (ii) of human endocan of SEQ ID NO: 1, in the said sample, c) determining the inflammatory state of the said subject from the ratio of the amount values of (i) the at least one enzyme proteolysis-resistant peptide measured at step b), to (ii) the human endocan measured at step b).
地址 Paris FR